Overview
Dr. R. Taylor Ripley is a professor of Surgery and the Meyer-DeBakey Chair in Investigative Surgery. He serves as director of the Mesothelioma Treatment Center, Thoracic Surgical Research, and Clinical Trials for the Michael E. DeBakey Department of Surgery. He is a nationally recognized, board-certified Thoracic Surgeon and an expert in mesothelioma, lung cancer, esophageal cancer, chest wall tumors, and chest wall reconstruction. Additionally, Dr. Ripley focuses on Costal Margin Reconstruction for Slipping Rib Syndrome. Dr. Ripley specializes in Robotic Surgery to provide minimally-invasive approaches to thoracic diseases. He also practices all aspects of thoracic surgery including infectious lung disease, benign esophageal disease, and endoluminal procedures. Dr. Ripley received the ‘Top Doctors’ award by the Houstonia Magazine and the ‘Star Faculty Award for Excellence in Patient Care'.Dr. Ripley focuses on the treatment of patients with mesothelioma in which he is the principal investigator of the actively enrolling trial, ‘NEMO: Combination of Induction Durvalumab and Tremelimumab alone versus Durvalumab and Tremelimumab with chemotherapy for Potentially Resectable Pleural Mesothelioma.’ In this trial, patients will receive the maximum treatment to beat this disease. Patients will undergo treatment with immunotherapy with or without chemotherapy, then they will undergo surgery with an extended pleurectomy decortication or extrapleural pneumonectomy, then they will receive one year of immunotherapy.Dr. Ripley leads the Ripley Lab for Translational Thoracic Oncology Research (Thoracic Surgical Oncology Translational Laboratory (bcm.edu)) in which he focuses on methods to undermine tumors ability to resist treatment. His laboratory is funded with two National Cancer Institute, NIH, R01 grants, ‘Targeting the Mitochondria to Overcome Resistance to Immune Checkpoint Inhibition in Malignant Pleural Mesothelioma,’ and ‘Novel strategies to improve mesothelioma therapy’. Additionally, he received an award from the DeGregorio Family Foundation Grant for Gastric and Esophageal Malignancies, ‘Targeting Mitochondrial Resistance to Apoptosis after Neoadjuvant Therapy in Esophageal Adenocarcinoma’ to improve treatment for patients with esophageal cancer.Prior to his faculty appointment at BCM, Dr. Ripley was an Associate Professor of Surgery at National Cancer Institute, NIH. Prior to the NIH faculty appointment, Dr. Ripley trained extensively in the care of patients with mesothelioma and thoracic cancers under world-renowned surgeons during his fellowship at Memorial Sloan-Kettering Cancer Center in New York. He also completed a fellowship in Surgical Oncology at the NCI, NIH. Dr. Ripley did general surgery residency at the University of Colorado and received his Medical Doctorate from Vanderbilt University.
Dr. Ripley is highly rated in 3 conditions, according to our data. His top areas of expertise are Mesothelioma, Metastatic Pleural Tumor, Fibrosing Mediastinitis, Pleuropulmonary Blastoma, and Thymectomy.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
7200 Cambridge St, 6th Floor, Ste 6A, Houston, TX 77030
MD Anderson
Nancy Perrier is a Surgical Oncologist and an Endocrinologist in Houston, Texas. Dr. Perrier is highly rated in 27 conditions, according to our data. Her top areas of expertise are Parathyroid Adenoma, Parathyroid Cancer, Hyperparathyroidism, Parathyroidectomy, and Thyroidectomy.
MD Anderson
Elizabeth Grubbs is a Surgical Oncologist and a General Surgeon in Houston, Texas. Dr. Grubbs is highly rated in 23 conditions, according to our data. Her top areas of expertise are Multiple Endocrine Neoplasia Type 2, Medullary Thyroid Carcinoma, Thyroid Cancer, Thyroidectomy, and Parathyroidectomy.
Baylor St. Luke's - O’Quinn Medical Tower At McNair
Dr. Alastair Thompson is a surgical oncologist specializing in breast cancer. He is the Professor and Chief of the Division of Surgical Oncology, Section of Breast Surgery at Baylor College of Medicine, where he holds the Olga Keith Wiess Chair of Surgery. He also serves as Co-Director of the Lester and Sue Smith Breast Center and is Co-Associate Director for Clinical Research at the Dan L Duncan Comprehensive Cancer Center.Dr. Thomspon’s clinical interests include: ductal carcinoma in situ (DCIS); nipple and skin sparing mastectomy; breast conservation surgery; and sentinel lymph node biopsy. His research interests include: multidisciplinary patient care alongside “bench to bedside” studies; and innovative clinical trials in cancer. He initiated and led a successful breast cancer laboratory program; provided leadership for a cancer center in the United Kingdom; chaired the UK national breast cancer trials portfolio of 120 studies; and engaged in a range of pivotal roles in key drug, radiation therapy and surgical trials involving the UK, Europe, United States and Australia.Dr. Thompson also has preclinical and practical experience in the design, implementation, monitoring and reporting of early- to late-phase drug and medical device trials. Dr. Thompson received his MBChB in Medicine Surgery and medical degree in Molecular Biology from the University of Edinburgh in Edinburgh, Scotland. He completed his residency in general surgery at the Royal Infirmary of Edinburgh and a Research Fellowship at the Imperial Cancer Research Fund in Edinburgh.Dr. Thompson has co-chaired the Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for low-risk DCIS; and the National Cancer Institute (NCI)-Breast Cancer Steering Committee proposed “no surgery” clinical trial planning committee. He is a member of the NCI BOLD taskforce and has held leadership positions in the Translational Breast Cancer Research Consortium and SWOG Cancer Research Network.Dr. Thompson is also a member of the American Society of Clinical Oncology, Association of Breast Surgery, British Association of Surgical Oncology, British Breast Group, American Society of Breast Surgeons, American Association for Cancer Research, Moynihan Chirurgical Club, and the Society of Surgical Oncology. Dr. Thompson is highly rated in 6 conditions, according to our data. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Tissue Biopsy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- MesotheliomaDr. Ripley isDistinguished. Learn about Mesothelioma.
- Advanced
- Metastatic Pleural TumorDr. Ripley isAdvanced. Learn about Metastatic Pleural Tumor.
- ThymectomyDr. Ripley isAdvanced. Learn about Thymectomy.
- Experienced
- Collapsed LungDr. Ripley isExperienced. Learn about Collapsed Lung.
- Fibrosing MediastinitisDr. Ripley isExperienced. Learn about Fibrosing Mediastinitis.
- Lung CancerDr. Ripley isExperienced. Learn about Lung Cancer.
- Mediastinal TumorDr. Ripley isExperienced. Learn about Mediastinal Tumor.
- PleurisyDr. Ripley isExperienced. Learn about Pleurisy.
- Pleuropulmonary BlastomaDr. Ripley isExperienced. Learn about Pleuropulmonary Blastoma.